Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Daehan Nupharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15,132	29,726	19,202	21,156	15,303	15,369
Short-Term Investments	1,000	820	1,820	1,494	820	830
Trading Asset Securities	7,765	6,971	2,758	6,720	6,197	4,981
Cash & Short-Term Investments	23,897	37,517	23,780	29,370	22,319	21,180
Cash Growth	8.99%	57.77%	-19.03%	31.59%	5.38%	17.26%
Accounts Receivable	32,368	34,037	35,108	32,950	26,510	26,795
Other Receivables	6,943	4,935	3,552	2,554	3,408	2,870
Receivables	40,011	39,672	39,959	37,104	31,878	31,375
Inventory	39,055	37,215	32,890	30,448	20,391	14,808
Prepaid Expenses	39.83	72.81	82.75	3,643	53.85	88.35
Other Current Assets	1,115	877.53	1,773	2,077	1,391	1,251
Total Current Assets	104,117	115,354	98,485	102,641	76,033	68,702
Property, Plant & Equipment	113,888	85,042	54,313	46,978	46,294	38,570
Long-Term Investments	14,476	17,874	21,420	18,042	20,513	8,402
Other Intangible Assets	1,185	1,122	563.83	336.14	423.59	369.7
Long-Term Deferred Tax Assets	1,209	1,164	1,418	594.43	10,327	12,443
Other Long-Term Assets	721.8	729.93	727.64	767.44	4,052	4,246
Total Assets	235,597	221,285	176,927	169,359	157,643	132,733
Accounts Payable	11,739	12,569	10,230	11,633	8,179	4,825
Accrued Expenses	6,876	8,248	7,496	6,608	5,787	3,188
Short-Term Debt	39,894	39,655	35,672	20,523	15,812	26,501
Current Portion of Long-Term Debt	-	-	-	13,461	4,700	2,620
Current Portion of Leases	487.01	531.14	556.37	426.7	442.09	611.65
Current Income Taxes Payable	883.45	2,232	1,988	-	4,180	5,533
Other Current Liabilities	4,993	8,646	5,815	5,932	5,948	7,840
Total Current Liabilities	64,871	71,881	61,758	58,584	45,049	51,119
Long-Term Debt	40,569	18,831	-	2,006	15,631	9,078
Long-Term Leases	369.54	409.87	369.21	226.1	335.16	384.84
Other Long-Term Liabilities	591.89	662.14	682.91	653.17	9,371	8,502
Total Liabilities	108,854	95,846	67,571	66,400	75,178	73,494
Common Stock	7,177	7,177	7,177	7,177	7,177	7,177
Additional Paid-In Capital	55,676	55,676	55,676	55,676	55,676	55,676
Retained Earnings	58,680	54,497	41,112	30,609	7,336	-7,708
Treasury Stock	-3,075	-3,075	-3,075	-3,075	-3,075	-3,075
Comprehensive Income & Other	8,285	11,163	8,466	12,572	15,351	7,168
Shareholders' Equity	126,743	125,439	109,356	102,959	82,465	59,239
Total Liabilities & Equity	235,597	221,285	176,927	169,359	157,643	132,733
Total Debt	81,319	59,427	36,598	36,642	36,920	39,195
Net Cash (Debt)	-57,422	-21,910	-12,818	-7,272	-14,601	-18,015
Net Cash Per Share	-4091.29	-1561.08	-913.25	-518.12	-1040.30	-1283.58
Filing Date Shares Outstanding	14.04	14.04	14.04	14.04	14.04	14.04
Total Common Shares Outstanding	14.04	14.04	14.04	14.04	14.04	14.04
Working Capital	39,246	43,473	36,727	44,058	30,984	17,583
Book Value Per Share	9030.34	8937.39	7791.50	7335.72	5875.57	4220.71
Tangible Book Value	125,558	124,317	108,792	102,623	82,042	58,869
Tangible Book Value Per Share	8945.89	8857.49	7751.32	7311.77	5845.39	4194.37
Land	13,776	13,589	13,021	13,021	12,938	8,642
Buildings	43,408	43,391	40,518	32,676	32,734	16,493
Machinery	32,132	31,095	30,107	26,974	25,859	22,784
Construction In Progress	59,299	29,948	1,143	2,366	179.45	13,301

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.